February 15, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis
📊 The healthcare sector has shown varied performances across different time horizons. This analysis provides insights into the equities' movements over the last week, month, and quarter, pinpointing significant trends and divergences. As investors adjust their portfolios, it is crucial to understand the dynamics and underlying factors influencing these stocks. This analysis aims to provide clarity and assist in informed decision-making.
Healthcare Stocks Performance One Week
🗣️ Over the past week, healthcare stocks demonstrated a mixed performance. UnitedHealth Group (UNH) led with an impressive gain, reflecting potential shifts in market sentiment. In contrast, Thermo Fisher (TMO) faced headwinds, marking a significant downturn. This period underscores the sector's volatility and potential for rapid change.
| Stock | Performance (%) | Performance |
|---|---|---|
| UNH | 5.90% | |
| ABBV | 3.61% | |
| ABT | 1.70% | |
| JNJ | 1.45% | |
| MRK | -0.33% | |
| ISRG | -0.39% | |
| LLY | -1.67% | |
| AMGN | -3.93% | |
| TMO | -7.16% |
Healthcare Stocks Performance One Month
📈 In the last month, Amgen (AMGN) and Merck (MRK) soared with double-digit gains, highlighting a bullish trend in specific healthcare segments. Meanwhile, Thermo Fisher Scientific (TMO) and UnitedHealth Group (UNH) experienced notable declines, suggesting sector-specific challenges. The diversity in performance accentuates the heterogeneous nature of the healthcare industry.
| Stock | Performance (%) | Performance |
|---|---|---|
| AMGN | 11.74% | |
| MRK | 11.20% | |
| JNJ | 10.82% | |
| ABBV | 7.93% | |
| LLY | 1.32% | |
| ISRG | -9.39% | |
| ABT | -7.07% | |
| UNH | -9.53% | |
| TMO | -19.97% |
Healthcare Stocks Performance Three Months
📉 Over the quarter, Merck (MRK) maintained its position as a strong performer in the healthcare sector, leading the pack with a substantial gain. Johnson & Johnson (JNJ) also enjoyed robust results. However, Abbott Laboratories (ABT) and Thermo Fisher (TMO) struggled, evidencing considerable challenges. These movements suggest a bifurcation in the sector where not all subsections are experiencing growth equally.
| Stock | Performance (%) | Performance |
|---|---|---|
| MRK | 27.71% | |
| JNJ | 20.23% | |
| AMGN | 8.86% | |
| LLY | 3.61% | |
| ABBV | -0.27% | |
| UNH | -5.76% | |
| TMO | -10.96% | |
| ISRG | -11.09% | |
| ABT | -13.36% |
Summary
✅ The analysis reveals distinct trends across various time frames in the healthcare sector. Merck (MRK) has emerged as a consistent leader over multiple periods, reinforcing its strong market positioning. Conversely, Thermo Fisher (TMO) has faced challenges, highlighting potential risks. Investors should note the sector's complexity and consider allocations carefully, leveraging insights from these performance metrics to optimize their portfolios.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years